Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Smoking and survival after radical cystectomy for bladder cancer.

Lee C, Kim KH, You D, Jeong IG, Hong B, Hong JH, Ahn H, Kim CS.

Urology. 2012 Dec;80(6):1307-12. doi: 10.1016/j.urology.2012.08.026. Epub 2012 Oct 5.

PMID:
23044645
[PubMed - indexed for MEDLINE]
2.

Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.

Rink M, Zabor EC, Furberg H, Xylinas E, Ehdaie B, Novara G, Babjuk M, Pycha A, Lotan Y, Trinh QD, Chun FK, Lee RK, Karakiewicz PI, Fisch M, Robinson BD, Scherr DS, Shariat SF.

Eur Urol. 2013 Sep;64(3):456-64. doi: 10.1016/j.eururo.2012.11.039. Epub 2012 Nov 27.

PMID:
23206854
[PubMed - indexed for MEDLINE]
3.

Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer.

Boström PJ, Alkhateeb S, Trottier G, Athanasopoulos PZ, Mirtti T, Kortekangas H, Laato M, van Rhijn B, van der Kwast T, Fleshner NE, Jewett MA, Finelli A, Zlotta AR.

BJU Int. 2012 Jan;109(1):70-6. doi: 10.1111/j.1464-410X.2011.10371.x. Epub 2011 Aug 18.

PMID:
21851540
[PubMed - indexed for MEDLINE]
5.

Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy.

Horikawa Y, Kumazawa T, Narita S, Inoue T, Yuasa T, Matsuura S, Nanjo H, Satoh S, Tsuchiya N, Habuchi T.

Int J Clin Oncol. 2007 Apr;12(2):131-6. Epub 2007 Apr 27.

PMID:
17443281
[PubMed - indexed for MEDLINE]
6.

A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.

Todenhöfer T, Renninger M, Schwentner C, Stenzl A, Gakis G.

BJU Int. 2012 Dec;110(11 Pt B):E533-40. doi: 10.1111/j.1464-410X.2012.11231.x. Epub 2012 May 11.

PMID:
22578156
[PubMed - indexed for MEDLINE]
7.

A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire.

Chahal R, Sundaram SK, Iddenden R, Forman DF, Weston PM, Harrison SC.

Eur Urol. 2003 Mar;43(3):246-57.

PMID:
12600427
[PubMed - indexed for MEDLINE]
8.

Cigarette smoking status at diagnosis and recurrence in intermediate-risk non-muscle-invasive bladder carcinoma.

Serretta V, Altieri V, Morgia G, Di Lallo A, Carrieri G, Allegro R; Gruppo Studi Tumori Urologici (GSTU) Foundation.

Urology. 2013 Feb;81(2):277-81. doi: 10.1016/j.urology.2012.09.040.

PMID:
23374781
[PubMed - indexed for MEDLINE]
9.

Factors influencing post-recurrence survival in bladder cancer following radical cystectomy.

Mitra AP, Quinn DI, Dorff TB, Skinner EC, Schuckman AK, Miranda G, Gill IS, Daneshmand S.

BJU Int. 2012 Mar;109(6):846-54. doi: 10.1111/j.1464-410X.2011.10455.x. Epub 2011 Aug 4.

PMID:
21812902
[PubMed - indexed for MEDLINE]
10.

Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.

Fairey AS, Jacobsen NE, Chetner MP, Mador DR, Metcalfe JB, Moore RB, Rourke KF, Todd GT, Venner PM, Voaklander DC, Estey EP.

J Urol. 2009 Jul;182(1):85-92; discussion 93. doi: 10.1016/j.juro.2008.11.111. Epub 2009 May 17.

PMID:
19447413
[PubMed - indexed for MEDLINE]
11.

Predicting the survival of bladder carcinoma patients treated with radical cystectomy.

Cheng L, Weaver AL, Leibovich BC, Ramnani DM, Neumann RM, Scherer BG, Nehra A, Zincke H, Bostwick DG.

Cancer. 2000 May 15;88(10):2326-32.

PMID:
10820355
[PubMed - indexed for MEDLINE]
12.

Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer.

Lammers RJ, Witjes WP, Hendricksen K, Caris CT, Janzing-Pastors MH, Witjes JA.

Eur Urol. 2011 Oct;60(4):713-20. doi: 10.1016/j.eururo.2011.07.010. Epub 2011 Jul 14.

PMID:
21794974
[PubMed - indexed for MEDLINE]
13.

Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.

Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.

J Urol. 2006 Aug;176(2):493-8; discussion 498-9.

PMID:
16813876
[PubMed - indexed for MEDLINE]
14.

Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer.

Rink M, Furberg H, Zabor EC, Xylinas E, Babjuk M, Pycha A, Lotan Y, Karakiewicz PI, Novara G, Robinson BD, Montorsi F, Chun FK, Scherr DS, Shariat SF.

Eur Urol. 2013 Apr;63(4):724-32. doi: 10.1016/j.eururo.2012.08.025. Epub 2012 Aug 21.

PMID:
22925575
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Prognostic factors and outcome in patients with T1 high-grade bladder cancer: can we identify patients for early cystectomy?

Segal R, Yafi FA, Brimo F, Tanguay S, Aprikian A, Kassouf W.

BJU Int. 2012 Apr;109(7):1026-30. doi: 10.1111/j.1464-410X.2011.10462.x. Epub 2011 Aug 24.

PMID:
21883838
[PubMed - indexed for MEDLINE]
16.

Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.

Stein JP, Cai J, Groshen S, Skinner DG.

J Urol. 2003 Jul;170(1):35-41.

PMID:
12796639
[PubMed - indexed for MEDLINE]
17.

Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer.

Rink M, Xylinas E, Babjuk M, Hansen J, Pycha A, Comploj E, Lotan Y, Sun M, Karakiewicz PI, Abdennabi J, Fajkovic H, Loidl W, Chun FK, Fisch M, Scherr DS, Shariat SF.

J Urol. 2012 Dec;188(6):2120-7. doi: 10.1016/j.juro.2012.08.029. Epub 2012 Oct 18.

PMID:
23083868
[PubMed - indexed for MEDLINE]
18.

Upper urinary tract recurrence after radical cystectomy for bladder cancer: incidence and risk factors.

Takayanagi A, Masumori N, Takahashi A, Takagi Y, Tsukamoto T.

Int J Urol. 2012 Mar;19(3):229-33. doi: 10.1111/j.1442-2042.2011.02916.x. Epub 2011 Nov 28.

PMID:
22121922
[PubMed - indexed for MEDLINE]
19.

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG.

J Clin Oncol. 2001 Feb 1;19(3):666-75.

PMID:
11157016
[PubMed - indexed for MEDLINE]
20.

Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.

Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI.

J Clin Oncol. 2005 Sep 20;23(27):6533-9. Epub 2005 Aug 22.

PMID:
16116151
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk